Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), also known as APO2L, has emerged as a highly potential anticancer agent because of its capacity to effectively trigger apoptosis in tumor cells by specifically binding to either of its death receptors (DR4 or DR5) while having no adver...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Mina Habibizadeh, Shima Lotfollahzadeh, Parisa Mahdavi, Soheila Mohammadi, Omid Tavallaei
Format:	Article
Language:	English
Published:	Elsevier 2024-08-01
Subjects:	TRAIL Gene delivery Nanoparticles Cancer cell resistance
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024120889